Trevena (TRVN) 10-K2016 FY Annual report

Filed: 8 Mar 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Alder, AMG, antiemetic, arrestin, ATHENA, Avanir, Biopharma, Botox, button, CALDOLOR, CGRP, clarify, Colucid, Cumberland, customary, cytoprotective, desaturation, dihydroergotamine, dry, DSUVIA, Eli, ergot, film, fit, floor, hedging, immaterial, indemnification, Innocoll, IntelGenx, inter, Journal, language, Lasmiditan, LIBOR, Lilly, liposomal, nasal, NOL, nonclinical, noncurrent, notified, OLINOVO, OLINVO, OLINVOTM, ONZETRA, Pharma, powder, prophylactic, propranolol, qui, reconciling, RedHill, reexamination, repeal, Republican, RIZAPORT, rizatriptan, saturation, sedation, SempranaTM, serum, spontaneously, sumatriptan, Teva, thin, top, topiramate, true, Trump, ubrogepant, Unaudited, venture, vowed, Wayne, Xsail, ZALVISO

Removed: accommodate, activated, activation, adapted, additive, ADHERE, adjustment, admission, alternatively, analyzed, andin, ARB, arrival, arterial, assume, attribution, baseline, bearing, block, blockade, breath, calcium, calculate, cardiac, cardiomyocyte, cardioprotective, caregiver, cascade, catheter, circulation, clinic, combining, comparing, complicated, conductance, congestive, contractility, converted, correlating, crossover, decompensated, deliver, description, discharge, document, dog, downstream, drift, dropped, elevated, elevation, Eleven, entrance, escalation, ESPVR, examine, expecting, experiencing, experimental, faith, freely, functioning, generation, GI, hemodynamic, hospitalization, hospitalized, hypertrophy, hypotension, ideally, incidence, incident, inin, kg, kidney, lab, lifted, losartan, lowered, MAP, mecarbil, micromanometer, mobilization, modulation, mutually, myofilament, necessitating, observed, omecamtiv, optionee, organ, orin, orqui, overload, paced, pathophysiology, PCWP, pendency, periodically, pharmacologic, PRA, practical, preservation, preserved, preserving, preventing, proceeded, prolonged, provisional, pump, RAS, realizability, recipient, reclassification, reclassified, recognizing, registry, release, renally, renegotiate, replaced, represent, restriction, revalued, reversed, reversible, reverted, routinely, SAB, sample, sensitization, serelaxin, sicker, size, Society, sodium, standing, steady, stimulated, sublicensee, sublicensing, subset, symptomatic, telmisartan, Thesein, throughin, tiered, titration, toxicology, ularitide, unbiased, uncured, urinary, walking, washout, weighed, withdrawn

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

TRVN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Of

Principal Executive Officer

Pursuant To 18 U.S.C. Section 1350,

As Adopted Pursuant To

Section 906 Of The Sarbanes‑Oxley Act Of 2002

In connection with the Annual Report of Trevena, Inc. (the “Company”) on Form 10‑K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Maxine Gowen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002, that to my knowledge:

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report.


Date: March 8, 2017	/s/ Maxine Gowen

	President and Chief Executive Officer
	(Principal Executive Officer)

This certification accompanies the Report and shall not be deemed “filed” by the Company with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.